Tech Company Financing Transactions
Field Medical Funding Round
On 7/1/2025, Field Medical secured $35 million in Series B funding from BioStar Capital, CUE Growth Partners and private investors.
Transaction Overview
Company Name
Announced On
7/1/2025
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series B
Investors
BioStar Capital (Lead Investor)
CUE Growth Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to initiate its pivotal VERITAS trial, advance the FieldForce Ablation System development, and further expand clinical and regulatory capabilities.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2611 S Coast Highway 101
Cardiff-by-the-Sea, CA 92007
USA
Cardiff-by-the-Sea, CA 92007
USA
Phone
Website
Email Address
Overview
Field Medical blends passion and experience to advance cardiac care. Our mission is to enable physicians, cardiologists, and patients to achieve the best possible outcomes during cardiac ablation procedures. We do this by building advanced pulsed field ablation catheters that are highly effective, yet minimize unintended impacts on surrounding areas of the body.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Mickelsen
Browse more venture capital transactions:
Prev: 7/1/2025: Gallant venture capital transaction
Next: 7/1/2025: Remark venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs